chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient given vaccine while sitting on mother lap. technique correct. mother stated daughter did not have issues in past with vaccines. Daughter became light headed after vaccine. Son was next, wished to sit on mothers lap, mother declined to wait and handed daughter to father. while prepping, daughter was put down next to father to stand. About 3 minutes post-administation, pt fainted and head audibly contacted tile floor. Was unconscious for ~30 seconds, awoke while I was calling 9-1-1. Breathing normalized upon awakening, CPR not administered after verifying with EMS. Mother still requested ambulance, EMS arrived approximately 2 minutes later while daughter was being held by father. Finished vaccinating brother and father per their request and allowed EMS to finish. let pt know to call if any further events.
No adverse effect reported; a patient received expired MMRII; This spontaneous report was received from a registered nurse and refers to a patient of an unknown age an gender. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies were not reported.  On 26-AUG-2019, the patient was vaccinated with an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), recombinant human albumin (rHA), lot # N023142 with an expiration date 24-AUG-2019 for prophylaxis (dose, route of administration and anatomical location were not reported). No adverse effect reported. No additional information provided.
Spontaneous Intracranial Hypotension,; Subdural hematoma; spontaneous  cranial spinal fluid leak;
Thrush infection.  Tongue has off white coating.  Burns and stings.  Began Tuesday night 4 days after my booster shot.
After getting shot #4 of my Anthrax series I got the normal lump and legion on my tricep.  4 Days later I was covered in hives and in the emergency room getting a shot of benadryl.
took an at home test and tested positive after testing; took an at home test and tested positive after testing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Oct2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 23 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Nut allergies" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 29May2022, outcome "unknown", COVID-19 (medically significant) with onset 29May2022, outcome "not recovered" and all described as "took an at home test and tested positive after testing". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative; (29May2022) Positive, notes: COVID infection occurred one week after finishing Paxlovid. Therapeutic measures were taken as a result of covid-19 with Pfizer Paxlovid from 17May2022 to 22May2022. Clinical course: Rebound COVID infection occurred one week after finishing Paxlovid. Symptoms were different this time around, but due to the number of rebound reports, she took an at home test and tested positive after testing negative to get out of quarantine.  Follow-Up (06Jun2022): Follow-up attempts are completed. No further information is expected.
fatigue, intestinal cramps, headache, loose bowels and pale stool. Cramps continue intermittently through current. Complete emptying of bowels occurred at 3PM on 4/28/2021, which was followed by constipation until 5/3.  Stool color returning to normal but cramps after eating occur.  Cramps have also occurred at night. Bland diet of tofu, rice, plain vegetables, citrus fruits and lots of liquids to include protein powder have helped, as does ginger. Weight loss of 10+ pounds in 2 weeks.
Lightheaded/ Woozy/ Fog Headed - Symptoms not listed on CDC website as reaction. Generalized weakness/Fatigue.
Localized reaction around injection site (redness and swelling) improved with BENADRYL.
(Received PREVNAR in past w/o reaction). Experienced normal soreness (L)UA evening of injection. Over next few days pain gradually increased in (L)UA to elbow - shoulder, shoulder blade and (L) side neck. Muscle pain, stiffness. Muscle contraction. Wearing sling to keep in neutral position pain 4 in AM and 7 by end of day. Using heat/ice. Seeing a neurologist and chiro per pt and receiving laser tx class 3 - heat to muscle/relax. Slowly improving still a problem, swollen. He is seen today because of left shoulder pain radiating to the tricipital area and left deltoid tenderness radiating to the left scapular area shortly after receiving the PNEUMOVAX immunization on March 21st; patient had no reaction to PREVNAR immunization. He was unable to enjoy his athletic activities. He underwent chiropractic treatments with some improvement in his discomfort; he never experienced tricipital edema, heat or erythema. Patient denies any trauma or fall; he remembers he had strained his left shoulder around a week prior to PNEUMOVAX immunization and has decreased his athletic activities to allow healing.
Immediate soreness around the injection site that progressively got worse as the day went on.  By 10:30 pm the same day my joints in my upper body began to ache and I was cold.  Slept seven hours and this morning woke up with intense pain at a #7 on a scale of 1-10 with 10 being the worst in every joint in my body with no energy.  I took a Tylenol and a Advil and stayed in bed until noon and now the pain is at a #3 being worse at sacral iliac joints and the injection site.
Patient received the gardasil vaccine on thursday august 23, 2007. on friday she fell and fractured her left wrist. on monday august 27, after a cast was put on her arm she began to have severe hives coming out all over her thys. her fingers were extremly swollen so i took her to the emergency room and they prescibed her predison
She got her vaccine, there was nothing that day or the next day.  On the 2nd day it started itching, and that was not a big deal as she has had that before.  Then it started wheeling up, the next day when she would rub on it to get the itching gone it would be very painful.  This lasted for about 8 days.  She has a little bit of soreness, a little lump, some itching and stiffness in her arm in the last couple of days.  She has not had any reactions to any other vaccines prior.  She took some Tylenol a night or not, but does she does take some allergy pills.   She called the pharmacist and he told her to call the CDC and they gave her our phone #.    She is concerned that one of her cousins had such a bad reaction that it caused an autoimmune problem and was in the hospital and a nursing home over a year and he said for her to tell her blood relatives not to take the vaccine.
Pt received Janssen Covid vaccine on 5/21/21. On 5/25/21, pt states she started having nausea, vomiting, diarrhea, and a migraine headache.  I told her if her symptoms don't improve in the next day or two, or if her symptoms worsen she should be seen.
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (fever). At the time of the report, pyrexia (fever) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No treatment medication provided.
Warmth  tingling on tongue and Lip  15 mins after vaccine Accelerate heart rate 120-130 7 hours after vaccine  accelerated heartrate  120 10 pm 5am 12/19/2020  Heartrate of 100 12 Noon 12/19/2020 Heartrate of 100 12/202020  10 am Accelerate heart rate of 100   12/20/2020  5 pm Accelerate of heartrate of 100  oral Benadryl 25mg in the ER
patient developed Hives  on Saturday afternoon into Evening after receiving vaccine on Thursday. he noted continue hives on Sunday along with a possible swelling/tightness in the lips Sunday.  He was able to take Benadryl and  Zyrtec and symptoms improved
Starting about 2 days after the vaccine I have had painful muscle and joint pain. It is painful whether I am stationary or moving...it doesn't seem to make a difference.  I take aleve to help with the pain.  I am questioning whether to go for the second dose in under3 weeks since the pain does not seem to be lessening after ten days.
for the past 2 to 3 weeks patient states her sciatica has been acting up to were she can not walk and she she is having nerve pain in her hair line where she has shingles in the past. I advised her to speak with her doctor.
Received Moderna vaccine on 01/28/21 and 2/26/21. COVID positive 1/6/22. Presented to ER on 1/11/22 and admitted. admitted on 1/11/22 for COVID-19 pneumonia.  Respiratory therapy was supplemental oxygen as needed was offered. Remdesivir and dexamethasone therapy but COVID-19 treatment protocol also initiated. Patient improved with resolution of symptoms. BP control optimization was employed. The patient was ultimately discharged home in stable condition and will follow-up with her PCP within 1 week. Discharged on 1/18/22
Pt states never felt well since having flu shot; sx general malaise, pleurisys, weakness, flu (chronic);
Systemic: Dizziness / Lightheadness-Severe, Systemic: Shortness of breath, wheezing-Severe
flu-like symptoms with fever; diarrhea; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms with fever), DIARRHOEA (diarrhea) and PYREXIA (fever) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M201A) for COVID-19 vaccination.     Medical history was not reported.  Concomitant products included SIMVASTATIN for an unknown indication.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms with fever), DIARRHOEA (diarrhea) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms with fever), DIARRHOEA (diarrhea) and PYREXIA (fever) had resolved.            Concominant medication also include an unknown anti-anxiety medication.  On 24 May 2021, the patient called and reported the first dose of the Moderna Covid-19 vaccine (Lot:031L201A, expiration: unknown) was received on 04 Feb 2021 at pharmacy.
ACUTE RESPIRATORY FAILURE 2/28/2023 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION ACUTE RESPIRATORY FAILURE 2/28/2023 HX OF ACUTE KIDNEY INJURY ACUTE RESPIRATORY FAILURE 2/28/2023 FEVER
PT WALKED IN C/O REACTION TO FLU SHOT HE RECEIVED 12/21/09, starting that day had pain, swelling, redness, warmth and sharp headache type sensations, he denies any trouble swallowing, breathing or tongue swelling, no rash otherwise, he has hx of MS and will see neurology 1/5/09, he denies new weakness, no leg problems, clumsiness or tingling. He is taking Benadryl starting last night which is helping.
approx 2yrs p/vax pt broke out w/chickenpox w/10-20 pox
had the vaccine but now has shingles; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 8-Jul-2022 Reporter's Comments: The patient's family member reported the case via interactive digital media. The reporter stated that his/ her family member had the vaccine but at the time of reporting had shingles. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
8x7 cm lump under arm/axilla. Monitor for any symptoms or fever, increase in swelling, redness, warmth. Keflex 500 mg PO tid X 10 days
Patient received vaccine on 18MAR2021. Unfortunately, he made it through our intake process and the nurse that administered the vaccine did not confirm the age. The nurse did try to reach the patient to confirm that there were no adverse reactions at home. She left a message.
This spontaneous report was received from a consumer concerning his friend's 1 months old baby of unknown gender. On an unknown date, the patient was vaccinated with 2 doses of BCG VACCINE (dose, route and lot number reported) in the same date. No other co-suspects were reported. No concomitant medications were reported. He indicated that there was no reaction to double dose yet. Additional information has been requested.
Initial case report received from a consumer on 22 OCT 2009. A female patient of unknown age was vaccinated i.m. with FLUVIRIN (batch no. unknown). The patient experienced shortly thereafter atrial fibrillation and gum bleeding and had an international normalized ratio (INR) of 3,5 and was hospitalized. Atrial fibrillation continued for 5 days. A cardioversion was done and normal rhythm was restored. She was discharged from hospital, but her INR remained elevated despite decreases in her COUMADIN dose. The patient had improved at the time of report. Concomitant medication: COUMADIN. On the same day we received again from the consumer the following additional information: The patient had a reaction and the event was still ongoing at time of the call. The outcome of the event was ongoing at the time of report. Reference no.: NA09-006905. Reference no.: NA09-006913. Addendum: On 23 OCT 2009 we received from a health care professional the following information. The caller confirmed that the vaccination date was 23 SEP 2009. The "COUMADIN level" was 2.3. After FLUVIRIN administration, the patient's gum began to bleed. She sought medical treatment in an emergency department. In the emergency department the patient's "COUMADIN level" was 3.5. "COUMADIN level" is interpreted as INR level. Reference no.: NA09-006965 2008/2009). Reference case no.: MA2009-3403 (FLUVIRIN 2008/2009).
Red and warm rash on left arm for the past 1 day.Treatment plan: Cephlexin 250 mg 2 tsps po Tid x days. Otc benadryl Q 4 to 6 hours until clear. Cool compress and ibuprofen prn.
I went to the ER because I had a fever of 103 and my blood pressure was 153/111 and it felt like my heart was racing. At the ER I stayed until 8am was given fluids.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 12-OCT-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K016966, expiry date: 10-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
mom claims that pts feet turned bright red & purple color is pale per mom; pt is sleepy per mom but is easily awakened; called clinic & spoke w/nurse; will be seen by CMG; MD felt might have been fr temperature;
74 Y/O female, BMI 47.5, PMHx of AFib, HTN, melanoma, thyroid disorder, and heart palpitations, admitted for weakness, cough, and SOB due to Covid on 11/22/21. Pt was diagnosed with Covid19 on 11/12/21. Chest x-ray from 11/22/21 indicates multifocal pneumonia. Covid treated with supportive care. Pt discharged to home with home health on 11/24/21.
Mother states red raised area on right leg appeared next day after vaccinations, child had slight temp. and fussy. on 3-28-03 mother reports lef raised area more raised and red area larger-OV NP and observed lef area to be red and raised 50mm in diam and feverish in site. Referred to family physician
This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX on left arm. The caller mentioned during conversation that a friend's wife had gotten SHINGRIX and experienced fever afterwards. No further details available. This case has been linked with US2018154148, reported by same reporter.
I received the flu shot 9/22/09. On 9/23/09 my R arm was scarred as if I had been burned. The scab is peeling now. I feel pain when I lay on it sometimes.
This is a spontaneous report received from a contactable consumer, patient. A 71-year-old elderly non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date (at the age of 71 years), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Concomitant medication was not reported. Patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: UNKNOWN), via an unspecified route of administration on 18Mar2021 at 16:00(at the age of 71 years) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 20Feb2021 at 16:00, the patient experienced dizziness which resulted in emergency room/department or urgent care. The patient did not receive any treatment for event. The clinical outcome of event dizziness was resolved with lasting effects on an unspecified date in 2021. No follow attempts are needed. Information about lot/batch number cannot be obtained.
Had fever, on 6/6/08, today 6/10/08 fussy, mom says vomiting.
Inconsolable crying for 35 minutes, hyperemic left lower extremity starting from the site of injection down to the thigh, leg , ankle and foot. After 30 minutes of excessive crying and persistence of the hyperemia 0.06 ml of epinephrine 1:100 was given SQ. Five minutes later, the hyperemia started to regress but did not disappear completely. The baby was still crying on and off. Mother was instructed to put cold compresses on the site of the injection, Tylenol 15 mgm/kg  Q 4 hours and to return to the clinic in AM, uness ( AFTER HOURS ) baby's temperature rises > 103 despite the Tylenol or the baby continues to have excessive  inconsolable crying.
Information has been received from a consumer concerning her two and half year old daughter who on 31-MAR-2008 was vaccinated IM with 0.5 mL of pneumococcal 23v polysaccharide vaccine (lot # 655290/0959F). The reporter reported that on 31-MAR-2008 her daughter developed fever and edema in her right leg from her knee to her thigh after receiving a dose of pneumococcal 23v polysaccharide vaccine. Follow up information received from the patient's mother stated that a magnetic resonance imaging (MRI) indicated her daughter had cellulitis. She also had a X-ray but result not reported. She was admitted to the hospital on 01-APR-2008. At the time of this report the patient had not recovered. Additional information has been requested.
Second dose given less than 25 days from first dose; Alopecia Areata, hair shredding; Skin patches; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA AREATA (Alopecia Areata, hair shredding), RASH (Skin patches) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given less than 25 days from first dose) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     There was a no medical history provided by the consumer.  Concomitant products included Multivitamins B12 and B6 for Product used for unknown indication, BIOTIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ALOPECIA AREATA (Alopecia Areata, hair shredding) and RASH (Skin patches). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given less than 25 days from first dose).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
small area of rash; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (For tolerance of 1st dose, refer case US2022AMR139883).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.  Linked case(s) involving the same patient:US2022AMR139883   Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got the shot of shingles vaccine second time.  The patient stated that, just a small area of rash. Additional Supportive Information: The follow up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR139883:same patient, other dose
Red raised circle around vaccine site-over 2-4 days it became swollen-hot- and skin hard to the touch. It both itched and hurt.
about 20 minutes after injection, pt alerted (rph) that she felt her tongue was swelling.  RPH could not see visible swelling.  RPH alerted me (pharmacist rph).  I spoke with pt and asked her to describe what her tongue felt like.  She stated no pain, just felt her tongue was getting bigger.  I took her to the restroom to look at her face in the mirror.  She stated her tongue looked slightly large, but not other swelling and no difficulty breathing.  She said she feels these sxs often when shes around pets or eats certain fruits.  She denied epipen, denied call to 911.  I offered 50 mg of diphenhydramine.  She only took 25 mg of diphenhydramine. she waited another 15 mins and said she felt fine.  I advised her to go to urgent care.  She left at 6:05 PM.  I called her at 6:45 and spoke with her daughter who states her mom is doing fine but she will monitor the next few hours.  I again advised trip to ER or urgent care if any new sxs or continued tongue swelling.
COMPLAINT OF HEADACHE SINCE VACCINE ADMINISTERED; RELIEVED BY TAKING TYLENOLNOT DEBILITATING AND NO OTHER SYMPTOMS